Reports

The SHC now recommends the PCV20 vaccine for children: it protects against 20 serotypes instead of 13, to better prevent serious pneumococcal infections. This new recommendation replaces the one issued in 2023...

Discover the SHC recommendations on yellow fever vaccination. This scientific opinion offers advice for travelers, healthcare professionals and vulnerable populations, with updates on revaccination and risk management. Download the report...

Discover the 2024 recommendations from the SHC on VRS vaccination for adults and seniors. A single dose for primary vaccination provides protection for at least 2 years, according to solid scientific data. Click to learn more!

This report provides recommendations for the Belgian vaccination strategy against COVID-19 in season 2024-2025. The focus is on the efficacy and safety of vaccines adapted to the Omicron variant and vaccination of pregnant women in particular.

This advisory report deals with the vaccination against seasonal flu and determines which population groups should be given priority for vaccination.

RSV (respiratory syncytial virus) is the leading cause of lower respiratory tract infections in babies under one year old. Every winter, it puts a huge strain on the healthcare system in Belgium. During 2024, two new preventive drugs will appear on the Belgian market to combat this virus...

Vaccination against meningococcal ACWY has been part of the basic vaccination schedule for children and adolescents since 2019. For certain risk groups, the SHC recommends the meningococcal group B vaccine, with booster doses for both vaccines depending on the group. This new advice provides an...

Since March 2023, the vaccine Qdenga® is available on the Belgian market. This vaccine reduces the risk of a severe course of dengue infection. The vaccine may be administered to children as young as 6 years old. Dengvaxia® is not available in Belgium and is not recommended to travellers.

In this scientific advisory report, which offers guidance to public health policy-makers, the Belgian Superior Health Council provides recommendations on mRNA COVID-19 vaccination for infants and children (preschool - 6 months to 5 years old) in Belgium. This report aims at providing the Belgian...

In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on vaccination against pneumococcal disease for adults.

In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides an update of the recommendations regarding the vaccination strategy against Monkeypox in the context of the European multi-country outbreak in May 2022. This ...

In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on the prevention of herpes zoster infections in the Belgian population.

In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on COVID-19 vaccination during the autumn/winter season of 2022-2023 for the Belgian population.

In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on the need for a second booster vaccination against COVID-19 for the adult population.

In this scientific advisory report, which offers guidance to public health policy-makers, the Belgian Superior Health Council provides recommendations on the need for a booster vaccination against COVID-19 for children and adolescents aged 12-17 years in Belgium.

In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on the need for booster vaccination against COVID-19 for immunocompromised individuals.

In this scientific advisory report, which offers guidance to public health policy-makers, the Belgian Superior Health Council provides recommendations regarding the pediatric vaccination against COVID-19 of children aged 5 to 11 years.

In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on the need for booster vaccination against COVID-19.

In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on the need for a  booster dose with an mRNA COVID-19 vaccine for individuals who received the Janssen (1 dose) vaccine for their primary...

In this scientific advisory report, which offers guidance to public health policy-makers, the Superior Health Council of Belgium provides recommendations on vaccination against COVID-19 for healthcare workers.